Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country
1
x
$
30.00
Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD
1
x
$
30.00
Psychopharmacology Bulletin VOL 48 No. 3, 2018 - Full Issue Stacked PDF
1
x
$
90.00
Clinical Management of Perinatal Depression: Focus on Paroxetine
1
x
$
30.00
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
1
x
$
30.00
Complete Resolution of Catatonia Following a Single Intravenous Lorazepam Challenge Test: An Early Intervention in Psychosis Case Report
1
x
$
30.00
Ranga Krishnan, MB, ChB: Evidence-Based Decision-Making in Psychopharmacology
1
x
$
30.00
Neuropharmacology of Paroxetine
1
x
$
30.00
First Episode Psychosis in a Teen with Narcolepsy and Cataplexy
1
x
$
30.00
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
1
x
$
30.00
View Cart
Checkout
Home
adverse-drug-reactions
“Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
$
30.00
Add to cart
Details
A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country
$
30.00
Add to cart
Details
A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach
$
30.00
Add to cart
Details
Page load link
Go to Top
